Anacor Pharmaceuticals Completes Enrollment in First of Two Phase 3 Trials of ... - Business Wire (press release)

Anacor Pharmaceuticals Completes Enrollment in First of Two Phase 3 Trials of ... - Business Wire (press release)
11/09/2011
Anacor Pharmaceuticals Completes Enrollment in First of Two Phase 3 Trials of ...Business Wire (press release)(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that it has completed enrollment in the first of two Phase 3 trials of tavaborole (formerly known as AN2690), a topical anti-fungal product candidate for the treatment of ...Anacor Pharmaceuticals Completes Enrollment In First Of Two Phase 3 Trials Of ...TheStreet.com (press release)Anacor Pharmaceuticals Completes Enrollment in First of Two Phase 3 Trials of ...MarketWatch (press release)all 15 news articles »

Anacor Pharmaceuticals Reports Third Quarter 2011 Financial Results - MarketWatch (press release)
11/10/2011
Anacor Pharmaceuticals Reports Third Quarter 2011 Financial ResultsMarketWatch (press release)Tavaborole -- our lead topical antifungal product candidate for the treatment of onychomycosis, a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States: -- Completed enrollment in the first of the ...and more »

Ask an Expert: Readers share tactics on toe fungus - The Tennessean
11/01/2011
Ask an Expert: Readers share tactics on toe fungusThe TennesseanTreatment and success of a great toenail fungus depends upon its severity. If the entire nail is extremely thick, yellowish and brittle and has progressed back to the root, you may need to see a podiatrist. When seeing a professional, there, too, ...

Nail Fungus  Nail Fungus Topical Treatments  Toenail Fungus